Sanofi Slapped With Securities Suit Over Obesity Drug
An institutional investor has launched a purported securities class action against Sanofi-Aventis accusing the pharmaceutical giant and several of its top executives of making misleading statements regarding its ill-fated obesity drug...To view the full article, register now.
Already a subscriber? Click here to view full article